Kilroy Realty Reports Mixed Q2 Results Amid West Coast Market Recovery
Event summary
- Q2 revenues declined to $272.4M from $289.9M in Q2 2025, with net income dropping to $19.9M from $68.4M.
- Signed approximately 376,000 square feet of leases, including a 38,000-square-foot lease with Olema Pharmaceuticals at KOP 2.
- Completed $202M in residential dispositions and expanded unsecured credit facilities by $150M.
- Stabilized portfolio occupancy was 77.0%, excluding Kilroy Oyster Point Phase 2 (KOP 2).
- Re-leasing spreads on comparable second-generation space were 27% (GAAP) and 16% (cash basis), excluding long-vacant spaces.
The big picture
Kilroy Realty's Q2 results reflect a mixed performance, with declining revenues and net income but strong leasing activity in West Coast markets. The company is capitalizing on growing demand against moderating high-quality supply, as evidenced by significant lease spreads and strategic dispositions. However, the broader economic conditions and competitive dynamics in commercial real estate will shape Kilroy's ability to maintain its financial flexibility and growth trajectory.
What we're watching
- Market Recovery Pace
- How the West Coast market recovery will impact Kilroy's leasing spreads and occupancy rates.
- Capital Recycling Strategy
- Whether Kilroy can sustain its capital recycling efforts amid fluctuating real estate valuations.
- Development Spending
- The pace at which Kilroy will adjust its development spending given the revised guidance of +/- $150M.